LBP-005 Efficacy, safety, tolerability, and immunogenicity of JNJ-0535 following a reduction of viral antigen levels through administration of siRNA JNJ-3989 in patients with chronic HBeAg negative hepatitis B-interim data of the OSPREY study

Autor: Bourgeois, Stefan, Buti, Maria, Gane, Edward J., Agarwal, Kosh, Janczewska, Ewa, Hsu, Yao-Chun (Holden), Brunetto, Maurizia, Lampertico, Pietro, Cabezas, Joaquin, Kim, Gloria, Slaets, Leen, Bakala, Adam, Vandenbossche, Joris, Verheijden, Simon, Fevery, Bart, De Creus, An, Biermer, Michael, Dimitrova, Dessislava
Zdroj: In Journal of Hepatology June 2024 80 Supplement 1:S79-S80
Databáze: ScienceDirect